Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18576337 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting D2E7-Early AS
Condition: Ankylosing Spondylitis
Intervention: Drug: Adalimumab 40 mg sc every other week

Study has passed its completion date and status has not been verified in more than two years.